- CA$136.53m
- CA$121.62m
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.01 | 5.26 | 6.94 | 24.8 | 40.5 |
Operating Profit | -4.01 | -5.26 | -6.94 | -24.8 | -40.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.97 | -5.32 | -6.97 | -24.4 | -39 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.97 | -5.32 | -6.97 | -24.4 | -39 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.97 | -5.32 | -6.97 | -24.4 | -39 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.97 | -5.32 | -6.97 | -24.4 | -39 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.023 | -0.027 | -0.028 | -0.089 | -0.129 |